Physical Activity Protects Against the Risk of Erosive Esophagitis on the Basis of Body Mass Index

Journal of Clinical Gastroenterology
Jeung Hui PyoJae J Kim

Abstract

To determine whether physical activity lowers the risk for erosive esophagitis on the basis of body mass index (BMI). Although previous studies have shown that physical activity is closely associated with erosive esophagitis, these data may be confounded by obesity. In this retrospective study, we included 182,409 patients who underwent an upper endoscopy and were diagnosed with erosive esophagitis. The impact of the amount and intensity of physical activity on the risk for erosive esophagitis was analyzed based on BMI groups. Subjects were classified into three BMI groups with equal numbers in each group. Overall, 10.3% (n=18,859) of patients were diagnosed with erosive esophagitis. After adjusting for confounding factors, a greater amount of exercise [lower tertile: odd ratio (OR), 0.86; 95% confidence interval (CI), 0.77-0.96; middle tertile: OR, 0.91; 95%, CI 0.84-1.00; upper tertile: OR, 0.79; 95% CI, 0.73-0.85) and increased exercise intensity (lower tertile, moderate: OR, 0.61; 95% CI, 0.52-0.71; vigorous: OR, 0.51; 95% CI, 0.44-0.58; middle tertile, moderate: OR, 0.62; 95% CI, 0.55-0.70; vigorous: OR, 0.58; 95% CI, 0.51-0.65; upper tertile, moderate: OR, 0.58; 95% CI, 0.53-0.65; vigorous: OR, 0.58; 95% CI, 0.53-0.64) wa...Continue Reading

References

Feb 1, 1993·Digestive Diseases and Sciences·E E SofferT E Adrian
Sep 19, 2000·Medicine and Science in Sports and Exercise·B E AinsworthA S Leon
Apr 18, 2001·Journal of Korean Medical Science·S C ChoiY H Nah
May 17, 2003·Medicine and Science in Sports and Exercise·Kimberly L CollingsPhilip B Miner
May 21, 2003·Alimentary Pharmacology & Therapeutics·B B DeanJ J Ofman
Feb 26, 2004·Current Sports Medicine Reports·Katrina Parmelee-Peters, James L Moeller
Mar 16, 2004·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Luke Bi, George Triadafilopoulos
Aug 17, 2004·The American Journal of Gastroenterology·John E PandolfinoPeter J Kahrilas
Sep 24, 2004·Alimentary Pharmacology & Therapeutics·J Y Kang
Sep 24, 2004·Alimentary Pharmacology & Therapeutics·A RuigómezJ Dent
Aug 3, 2005·Annals of Internal Medicine·Howard HampelHashem B El-Serag
Dec 13, 2005·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·N RaviJ V Reynolds
Jan 6, 2006·Alimentary Pharmacology & Therapeutics·M NoconS N Willich
May 2, 2006·Sports Medicine·Pawel JozkowLeszek Paradowski
May 10, 2006·Archives of Internal Medicine·Tonya KaltenbachLauren B Gerson
Feb 13, 2008·Gut·Hashem El-Serag
Apr 11, 2009·World Journal of Gastroenterology : WJG·Davide FestiAntonio Colecchia
Jun 18, 2011·Medicine and Science in Sports and Exercise·Barbara E AinsworthArthur S Leon
Feb 14, 2012·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Woon Geon ShinUNKNOWN Korean College of Helicobacter and Upper Gastrointestinal Research
Jan 30, 2013·The American Journal of Gastroenterology·Eivind Ness-JensenKristian Hveem
Sep 25, 2015·Heart and Vessels·Jidong SungKyung Pyo Hong
Apr 14, 2016·The American Journal of Gastroenterology·Thomas V K HerregodsAndré J P M Smout
Mar 23, 2017·World Journal of Surgery·Daniel A Kroch, Ryan D Madanick

❮ Previous
Next ❯

Citations

Jul 3, 2021·International Journal of Environmental Research and Public Health·Eunchan MunSoyoung Park

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.